Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC140 long non-coding RNA (CCDC140 lncRNA) is a transcript classified as a long non-coding RNA (lncRNA), typically defined as RNA molecules longer than 200 nucleotides that do not encode proteins[4][5][6]. The CCDC140 gene is mostly noted for its lncRNA form and shows limited expression in select higher primates[4]. LncRNAs perform various roles including the regulation of gene expression, chromatin organization, scaffolding of protein complexes, and modification of epigenetic states[1][2][3][5]. CCDC140 lncRNA is affiliated with epigenetic regulation and gene expression, and diseases associated with CCDC140 include Waardenburg syndrome type 1 and brain meningioma, suggesting roles in development and potentially in oncogenesis[4]. There is no evidence to indicate that CCDC140 lncRNA encodes a functional receptor, enzyme, or other established therapeutic target class[4][5][6]. No drugs are currently known to selectively target this lncRNA, and it is not considered a conventional therapeutic target. There is also limited disease biomarker data, and detailed safety concerns for therapeutic targeting are not known. CCDC140 lncRNA is a long non-coding RNA, not a receptor or classic drug target molecule. It is involved in regulation of gene expression and possibly chromatin organization but lacks established drug interactions[4][5]. It has associations with certain diseases but no established mechanisms of drug action or usage as a clinical biomarker. Its main scientific value is in basic research rather than as a therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 140 long non-coding RNA (CCDC140 lncRNA).